Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
MyMonitor.ai is a clinical pilot AI skin health platform developed by MyMonitor Corporation. It targets dermatology care, hospital systems, public health, medical education, life sciences, and pharmaceutical clinical research. The platform emphasizes “inclusive AI,” with a focus on AI-based skin lesion assessment, melanin-aware imaging, skin-tone-adjusted analysis, and participant recruitment and retention for clinical trials.
The platform supports multispectral imaging, melanin-compensated lesion detection, real-time flare tracking, disease progression monitoring, and standardized scores such as PASI, EASI, and VASI. The patient workflow described on the official website includes consultation, image capture via smartphone or clinical device, AI processing within 5 seconds, and the delivery of clinical insights plus relevant research enrollment prompts. On the research side, it supports outreach via email, SMS, and voice, along with cultural trust mapping, diverse enrollment, and predictive retention reminders. The website also claims κ>0.90 concordance with dermatologists, a 60% reduction in diagnostic time, and a 40% increase in diverse enrollment, but it does not disclose the model architecture, training data scale, or specific validation papers.
Access is currently mainly available via Request a Demo. Public pricing, free usage quotas, and trial periods are not disclosed. The terms indicate that some features may be paid, subscription fees are generally non-refundable where applicable, and payments are handled by third parties. For integration, the website lists Epic, Cerner, REDCap, Hugo, and Salesforce Health Cloud, and also mentions SDKs, mobile apps, wearables, and dashboards, suggesting that it is positioned more as enterprise-grade healthcare and research infrastructure.
Its strengths are that it covers clinical care, follow-up, research evidence generation, and clinical trial participation management, while placing particular emphasis on darker skin tones and fairness across diverse skin tones—an important real-world issue in dermatology AI. On data privacy, the materials mention HIPAA, CCPA, de-identification/anonymization of research data, and a federated learning architecture. The limitations are also clear: the terms state that MyMonitor.ai does not diagnose, treat, or prevent disease, and is only a tool for research, monitoring, and clinical decision support, not a replacement for physician judgment. It also does not guarantee accuracy, reliability, or availability. Information on pricing, regulatory approvals, SLAs, and deployment case studies is limited.
It is better suited to hospital dermatology departments, clinical research organizations, pharmaceutical companies/CROs, and teams that need to manage participants across diverse skin tones. It is not particularly suited to direct purchase by general consumers. The official materials do not specify accessibility from China, and network access and payment options are unknown. Medical compliance, cross-border data transfer, and local EHR integration would likely be the main barriers to adoption. Comparable products include SkinVision, Miiskin, VisualDx, DermEngine, as well as domestic hospital imaging AI or dermatology assisted-diagnosis solutions in China.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on mymonitor.ai official site.
mymonitor.ai is an United States AI Apps provider. TG4G tracks its product information, an overall rating of 7.0/10, and a China-accessibility score of Workable. Click "Visit Official Site" to reach mymonitor.ai directly.